Skip to main content
Clinical Trials/NCT02915328
NCT02915328
Unknown
Not Applicable

Role of the Type of Carotid Stent and Cerebral Protection on Cerebral Microembolization During Carotid Artery Stenting. A Randomized Study Comparing Carotid Wallstent vs Roadsaver® Stent and Distal vs Proximal Protection.

Centro Cardiologico Monzino1 site in 1 country100 target enrollmentApril 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Carotid Stenosis
Sponsor
Centro Cardiologico Monzino
Enrollment
100
Locations
1
Primary Endpoint
number of microembolization signals (MES) detected with transcranial doppler
Last Updated
9 years ago

Overview

Brief Summary

Stenting is an alternative to traditional surgery in the treatment of carotid stenosis.The intra and/or postprocedural cerebral embolization remains the most frequent complication.

The type of carotid stent and of cerebral protection are the two most important variables potentially affecting the rate of cerebral microembolization. So far there no consensus on the the best stent and cerebral protection.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
April 2018
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Centro Cardiologico Monzino
Responsible Party
Principal Investigator
Principal Investigator

Piero Montorsi

MD

Centro Cardiologico Monzino

Eligibility Criteria

Inclusion Criteria

  • significant, unilateral carotid artery stenosis with soft plaque defined as:
  • symptomatic patients: \> 1.3 m/sec peak systolic velocity and \> 50% diameter stenosis by Doppler ultrasound and \< 60 hounsfield unit by CT angiography
  • asymptomatic patients \> 2.5 m/sec peak systolic velocity and \> 70% diameter stenosis by Doppler ultrasound and \< 60 hounsfield unit by CT angiography

Exclusion Criteria

  • severe cerebral vasculopathy with cognitive impairment
  • contraindication to double antiplatelet treatment
  • controlateral carotid occlusion

Outcomes

Primary Outcomes

number of microembolization signals (MES) detected with transcranial doppler

Time Frame: intraprocedural

different phases of carotid stenting (lesion wiring; predilation; stent crossing of the lesion; stent deployment; stent post dilation; device retrieval/deflation

Secondary Outcomes

  • 6 month clinical follow up(6 month)
  • Doppler ultrasound assesment(day 2 or day 3, 1 month and 6 month)
  • Clinical success(day 2 or day 3 and day 30 complication)

Study Sites (1)

Loading locations...

Similar Trials